Historical perspective and clinical implications of the Pelger-Huet cell

American Journal of Hematology

Volumn 84, Issue 2, 2009, Pages 116-119

  Cunningham, John M ^a   Patnaik, Mrinal M ^b   Hammerschmidt, Dale E ^a   Vercellotti, Gregory M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HETEROCHROMATIN PROTEIN 1; SCAFFOLD PROTEIN;

AUTOSOMAL DOMINANT INHERITANCE; BLOOD SMEAR; BONE DYSPLASIA; CALCIFICATION; CELL NUCLEUS MEMBRANE; CELL STRUCTURE; CHEMOTAXIS; CHROMATIN STRUCTURE; CHROMOSOME 1Q; CHROMOSOME ABERRATION; CYTOPENIA; CYTOPLASM; FATALITY; GENETIC DISORDER; HUMAN; HYDROPS; LEUKOCYTE DISORDER; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; NONHUMAN; NONSENSE MUTATION; NUCLEAR LAMINA; PRIORITY JOURNAL; RESPIRATORY BURST; REVIEW;

ANIMALS; CELL NUCLEUS; CHILD; DIAGNOSIS, DIFFERENTIAL; EOSINOPHILS; FEMALE; FETAL DEATH; GENES, DOMINANT; HISTORY, 20TH CENTURY; HUMANS; INFECTION; LEUKEMIA, MYELOID; MYELODYSPLASTIC SYNDROMES; NETHERLANDS; NEUTROPHILS; PEDIGREE; PELGER-HUET ANOMALY; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 59949091453     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21320     Document Type: Review

References (38)

1. Pelger K. Ndld Tschr Geneesk 1928; 72:1178.
2. Huet GJ. Uber eine bisher unbekannte familiare anomalie der leukocyten. Klinische Wochenschrift 1932; 2:1264-1266.
3. Van Der Sar A. The Pelger-Huet's familiar nuclear anomaly of the leukocytes. Am J Clin Pathol 1944; 14:544-548.
4. Skendzel LP, Hoffman GC. The pelger anomaly of leukocytes: Forty-one cases in seven families. Am J Clin Pathol 1962; 37:294-301.
5. Karl H. Die besondere Haufung vong Merkmalstragern der Pelger-Huet-Kernanomalie der Leukozyten in Gelenau im Erzgebirge, Thesism. Berlin: Humboldt Univ; 1967.
6. Nachtsheim H. Pelgeranomaly in man and rabbit: A Mendelian character of the nuclei of leukocytes. J Hered 1950; 41:131-137.
7. Aznar J, Vaya A. Homozygous form of the Pelger-Huet leukocyte anomaly in man. Acta Haematol 1981; 66:59-62.
8. Haverkamp B, Van Lookeren CA. Homozygous form of Pelger-Huet's nuclear anomaly in man. Acta Haematol 1952; 7:295-303.
9. Adediran IA, Durosinmi MA. Peripheral blood and bone marrow changes in patients with acquired immunodeficiency syndrome. Afr J Med Med Sci 2006; 35:85-91.
10. Savage PJ, Dellinger RP, Barnes JV, Carruth CW. Pelger-Huet anomaly of granulocytes in a patient with tuberculosis. Chest 1984; 85:131-132.
11. van Hook L, Spivack C, Duncanson FP. Acquired Pelger-Huet anomaly associated with Mycoplasma pneumoniae pneumonia. Am J Clin Pathol 1985; 84:248-251.
12. Hoffman R. Hematology: Basic Principles and Practice. Philadelphia, PA: Churchill Livingstone (An Imprint of Elsevier); 2005.
13. Kuriyama K, Tomonaga M, Matsuo T, et al. Diagnostic significance of detecting pseudo-Pelger-Huet anomalies and micro-megakaryocytes in myelodysplastic syndrome. Br J Haematol 1986; 63:665-669.
14. Hoffmann K, Dreger CK, Olins AL, et al. Mutations in the gene encoding the lamin B receptor produce an altered nuclear morphology in granulocytes (Pelger-Huet anomaly). Nat Genet 2002; 31:410-414.
15. Sessarego M, Ajmar F. Correlation between acquired pseudo-Pelger-Huet anomaly and involvement of chromosome 17 in chronic myeloid leukemia. Cancer Genet Cytogenet 1987; 25:265-270.
16. Asmis LM, Hadaya K, Majno P, et al. Acquired and reversible Pelger-Huet anomaly of polymorphonuclear neutrophils in three transplant patients receiving mycophenolate mofetil therapy. Am J Hematol 2003; 73:244-248.
17. May RB, Sunder TR. Hematologic manifestations of long-term valproate therapy. Epilepsia 1993; 34:1098-1101.
18. Kaplan JM, Barrett O Jr. Reversible pseudo-Pelger anomaly related to sulfisoxazole therapy. N Engl J Med 1967; 277:421-422.
19. Taegtmeyer AB, Halil O, Bell AD, et al. Neutrophil dysplasia (acquired pseudopelger anomaly) caused byganciclovir. Transplantation 2005; 80:127-130.
20. Deutsch PH, Mandell GL. Reversible Pelger-Huet anomaly associated with ibuprofen therapy. Arch Intern Med 1985; 145:166.
21. Juneja SK, Matthews JP, Luzinat R, et al. Association of acquired Pelger- Huet anomaly with taxoid therapy. Br J Haematol 1996; 93:139-141.
22. Tomonaga M. Nuclear abnormalities in Pelger-Huet anomaly; progress in blood cell morphology. Rinsho Byori 2005; 53:54-60.
23. Best S, Salvati F, Kallo J, et al. Lamin B-receptor mutations in Pelger-Huet anomaly. Br J Haematol 2003; 123:542-544.
24. Cohen TV, Klarmann KD, Sakchaisri K, et al. The lamin B receptor under transcriptional control of C/EBPepsilon is required for morphological but not functional maturation of neutrophils. Hum Mol Genet 2008; 17:2921-2933.
25. Dechat T, Pfleghaar K, Sengupta K, et al. Nuclear lamins: Major factors in the structural organization and function of the nucleus and chromatin. Genes Dev 2008; 22:832-853.
26. Goldberg M, Harel A, Gruenbaum Y. The nuclear lamina: Molecular organization and interaction with chromatin. Crit Rev Eukaryot Gene Expr 1999; 9:285-293.
27. Oosterwijk JC, Mansour S, van Noort G, et al. Congenital abnormalities reported in Pelger-Huet homozygosity as compared to Greenberg/HEM dysplasia: Highly variable expression of allelic phenotypes. J Med Genet 2003; 40:937-941.
28. Waterham HR, Koster J, Mooyer P, et al. Autosomal recessive HEM/Greenberg skeletal dysplasia is caused by 3 beta-hydroxysterol delta 14-reductase deficiency due to mutations in the lamin B receptor gene. Am J Hum Genet 2003; 72:1013-1017.
29. Gruenbaum Y, Margalit A, Goldman RD, et al. The nuclear lamina comes of age. Nat Rev Mol Cell Biol 2005; 6:21-31.
30. Schneiderman LJ, Sampson WI, Schoene WC, Haydon GB. Genetic studies of a family with two unusual autosomal dominant conditions: Muscular dystrophy and Pelger-Huet anomaly. Clinical, pathologic and linkage considerations. Am J Med 1969; 46:380-393.
31. Cunningham I, MacCallum SJ, Nicholls MD, et al. The myelodysplastic syndromes: An analysis of prognostic factors in 226 cases from a single institution. Br J Haematol 1995; 90:602-606.
32. Johnson CA, Bass DA, Trillo AA, et al. Functional and metabolic studies of polymorphonuclear leukocytes in the congenital Pelger-Huet anomaly. Blood 1980; 55:466-469.
33. Park BH, Dolen J, Snyder B. Defective chemotactic migration of polymorpho- nuclear leukocytes in Pelger-Huet anomaly. Proc Soc Exp Biol Med 1977; 155:51-54.
34. Gaines P, Tien CW, Olins AL, et al. Mouse neutrophils lacking lamin B-receptor expression exhibit aberrant development and lack critical functional responses. Exp Hematol 2008; 36:965-976.
35. Shetty VT, Mundle SD, Raza A. Pseudo Pelger-Huet anomaly in myelodysplastic syndrome: Hyposegmented apoptotic neutrophil? Blood 2001; 98:1273-1275.
36. Lai JL, Zandecki M, Fenaux P, et al. Translocations (5;17) and (7;17) in patients with de novo or therapy-related myelodysplastic syndromes or acute nonlymphocytic leukemia. A possible association with acquired pseudoPelger-Huet anomaly and small vacuolated granulocytes. Cancer Genet Cytogenet 1990; 46:173-183.
37. Economopoulou C, Pappa V, Kontsioti F, et al. Analysis of apoptosis regulatory genes expression in the bone marrow (BM) of adult de novo myelodysplastic syndromes (MDS). Leuk Res 2008; 32:61-69.
38. Soenen V, Preudhomme C, Roumier C, et al. 17p Deletion in acute myeloid leukemia and myelodysplastic syndrome. Analysis of breakpoints and deleted segments by fluorescence in situ. Blood 1998; 91:1008-1015.